Neuroectodermal Tumors, Primitive clinical trials
The registry lists 140 studies for Neuroectodermal Tumors, Primitive across more than 10 countries. 23 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-22.
Status
- Completed
- 88
- Recruiting
- 19
- Terminated
- 11
- Status unknown
- 8
- Withdrawn
- 5
- Active, not recruiting
- 4
Phase
- Phase 2
- 58
- Phase 1
- 57
- Phase 3
- 7
- Early Phase 1
- 2
Where
- United States
- 115
- Canada
- 19
- Australia
- 10
- United Kingdom
- 8
- France
- 8
- Germany
- 7
Who runs them
National Cancer Institute (NCI) (41) · Children's Oncology Group (12) · M.D. Anderson Cancer Center (4) · St. Jude Children's Research Hospital (4) · Seattle Children's Hospital (3) · Pediatric Brain Tumor Consortium (3) · City of Hope Medical Center (3) · Universitätsklinikum Hamburg-Eppendorf (3)
Studies
Recruiting first, then most recently updated. Showing 50 of 140 — search for more.
- GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young AdultsRecruitingNCT07087002Phase 11 country
- HSV G207 in Children With Recurrent or Refractory Cerebellar Brain TumorsRecruitingNCT03911388Phase 11 country
- Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and SarcomasRecruitingNCT06465199Phase 1/21 country
- B7-H3.CD28Z.CART in CNS NeoplasmsRecruitingNCT07390539Phase 11 country
- A Phase 3 Study of Ersodetug in Patients With Tumor HyperinsulinismRecruitingNCT06881992Phase 35 countries
- C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)RecruitingNCT04099797Phase 11 country
- Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post ConsolidationRecruitingNCT06942039Early Phase 11 country
- Embryonal Tumor With Multilayered RosettesRecruitingNCT06861244Phase 21 country
- Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)RecruitingNCT06193759Phase 11 country
- ETMR One: An International Registry and Research Platform for Children With Embryonal Tumor With Multilayer RosettesRecruitingNCT047946861 country
- Natural History and Management of Von Hippel-Lindau (VHL) Associated Pancreatic Neuroendocrine TumorsRecruitingNCT04074135Phase 21 country
- Agnostic Therapy in Rare Solid TumorsRecruitingNCT06638931Phase 21 country
- Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System TumorsRecruitingNCT04185038Phase 11 country
- An Intermediate Expanded Use Trial of DFMOAvailableNCT035812401 country
- Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain CancerRecruitingNCT05106296Phase 11 country
- Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System NeoplasmsRecruitingNCT04541082Phase 11 country
- Intermediate-Size Cohort EAP for Ersodetug in Patients With Inadequately Controlled Hypoglycemia Related to a TumorAvailableNCT07262970
- Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid TumorsRecruitingNCT02508038Phase 11 country
- Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL TrialRecruitingNCT07167329Phase 21 country
- International PPB/DICER1 RegistryRecruitingNCT033821581 country
- 5-Aminolevulinic Acid (5-ALA) Gliolan®: Usage Increase Proposal for Neurosurgical Procedures in High-Grade GliomasNot yet recruitingNCT058503771 country
- Spanish Series of Patients Treated With the Radionuclide Lutetium177RecruitingNCT049492821 country
- A Study of HX008 Plus Transcatheter Arterial Chemoembolization (TACE) in the First-Line Treatment of Subjects With Stage IV (M1c) Melanoma That is Metastatic to the LiverNot yet recruitingNCT05647954Phase 31 country
- Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System TumorsCompletedNCT014452881 country
- Rare CNS Tumors Outcomes &RiskCompletedNCT032519891 country
- Vaccine Immunotherapy for Recurrent Medulloblastoma and Primitive Neuroectodermal TumorCompletedNCT01326104Phase 21 country
- Dose Escalation Study of CLR 131 in Pediatric Relapsed/Refractory Malignant Tumors Including Neuroblastoma and SarcomasActive, not recruitingNCT03478462Phase 13 countries
- EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS TumorsCompletedNCT03638167Phase 11 country
- HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS TumorsActive, not recruitingNCT03500991Phase 11 country
- International Society of Paediatric Oncology (SIOP) PNET 5 MedulloblastomaActive, not recruitingNCT02066220Phase 2/316 countries
- Multicenter Register for Children and Young Adults With Intracranial Localized Medulloblastoma, CNS-PNET or EpendymomaCompletedNCT022388991 country
- A Clinical and Molecular Risk-Directed Therapy for Newly Diagnosed MedulloblastomaActive, not recruitingNCT01878617Phase 24 countries
- Molecular-Guided Therapy for Childhood CancerCompletedNCT02162732Not applicable2 countries
- 131I-omburtamab for the Treatment of Central Nervous System/Leptomeningeal Neoplasms in Children and Young AdultsNo longer availableNCT050643061 country
- Busulfan, Melphalan, Topotecan Hydrochloride, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid TumorCompletedNCT00638898Phase 11 country
- Vemurafenib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With BRAF V600 Mutations (A Pediatric MATCH Treatment Trial)CompletedNCT03220035Phase 22 countries
- Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)CompletedNCT03233204Phase 22 countries
- Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain CancerWithdrawnNCT04521946Phase 1
- SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain TumorsCompletedNCT03434262Phase 11 country
- Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)TerminatedNCT02624388Phase 21 country
- Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid TumorsCompletedNCT03037385Phase 1/213 countries
- Auto Transplant for High Risk or Relapsed Solid or CNS TumorsCompletedNCT01505569Not applicable1 country
- Treatment of Patients With Newly Diagnosed Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid TumorCompletedNCT00085202Phase 33 countries
- Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid TumorsCompletedNCT01661400Phase 11 country
- HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain TumorsCompletedNCT02457845Phase 11 country
- Stereotactic Radiosurgery in Treating Patients With Brain TumorsCompletedNCT00019578Phase 11 country
- Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or SarcomasCompletedNCT02304458Phase 1/22 countries
- Collecting and Storing Biological Samples From Patients With Ewing SarcomaCompletedNCT008999906 countries
- Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain TumorsCompletedNCT02444546Phase 11 country
- NAC to Prevent Cisplatin-induced Hearing LossCompletedNCT02094625Phase 11 country